PMID- 23747813 OWN - NLM STAT- MEDLINE DCOM- 20140205 LR - 20240229 IS - 1872-6240 (Electronic) IS - 0006-8993 (Linking) VI - 1523 DP - 2013 Jul 26 TI - Puerarin attenuates neuronal degeneration in the substantia nigra of 6-OHDA-lesioned rats through regulating BDNF expression and activating the Nrf2/ARE signaling pathway. PG - 1-9 LID - S0006-8993(13)00809-3 [pii] LID - 10.1016/j.brainres.2013.05.046 [doi] AB - An increasing number of studies suggest that oxidative stress is associated with the Parkinsonian process. This study evaluated the potential neuroprotective role of puerarin (PR) on lesioned substantia nigra (SN) induced by 6-hydroxydopamine (6-OHDA). Data from a rotational test showed that PR treatment significantly decreased apomorphine-induced rotations. Both the dopamine (DA) content in the SN and the endogenous expression of brain-derived neurotrophic factor (BDNF) were also elevated by the treatment. Pathological examination showed that dopaminergic neuronal degeneration in the SN was attenuated by PR treatment. Meanwhile, the contents of gamma-glutamylcysteine synthetase (gamma-GCS), glutathione (GSH) and catalase (CAT) in SN tissue were gradually elevated. Additionally, cytochrome c oxidase (COX) mRNA expression in the SN was markedly up-regulated. At the same time, nuclear factor E2-related factor 2 (Nrf2) and Kelch-like ECH-associated protein 1 (Keapl) levels were progressively increased by the PR treatment. Our findings indicated that puerarin effectively protects against 6-OHDA-mediated oxidative stress injury in SN neurons, in which the underlying mechanisms are involved in modulating BDNF expression and activating the Nrf2/ARE signaling pathway. CI - Copyright (c) 2013 Elsevier B.V. All rights reserved. FAU - Li, Rong AU - Li R AD - Guilin Medical University, Guilin, Guangxi 541004, PR China. FAU - Liang, Tao AU - Liang T FAU - Xu, Lingyuan AU - Xu L FAU - Zheng, Ni AU - Zheng N FAU - Zhang, Kefeng AU - Zhang K FAU - Duan, Xiaoqun AU - Duan X LA - eng PT - Journal Article DEP - 20130605 PL - Netherlands TA - Brain Res JT - Brain research JID - 0045503 RN - 0 (Antioxidants) RN - 0 (Brain-Derived Neurotrophic Factor) RN - EC 1.11.1.6 (Catalase) RN - VTD58H1Z2X (Dopamine) RN - EC 1.9.3.1 (Electron Transport Complex IV) RN - EC 6.3.2.2 (Glutamate-Cysteine Ligase) RN - GAN16C9B8O (Glutathione) RN - 0 (Hydroxydopamines) RN - 0 (Intracellular Signaling Peptides and Proteins) RN - 0 (Isoflavones) RN - 0 (KEAP1 protein, rat) RN - 0 (Kelch-Like ECH-Associated Protein 1) RN - 0 (Neuroprotective Agents) RN - Z9W8997416 (puerarin) RN - 0 (Sympatholytics) RN - 0 (NF-E2-Related Factor 2) SB - IM MH - Animals MH - Male MH - Rats MH - *Antioxidants/adverse effects/pharmacology MH - Blotting, Western MH - *Brain-Derived Neurotrophic Factor/biosynthesis MH - Catalase/metabolism MH - Dopamine/metabolism MH - Electron Transport Complex IV/metabolism MH - Glutamate-Cysteine Ligase/metabolism MH - Glutathione/metabolism MH - Hydroxydopamines MH - Immunohistochemistry MH - Intracellular Signaling Peptides and Proteins/biosynthesis/genetics MH - *Isoflavones/adverse effects/pharmacology MH - Kelch-Like ECH-Associated Protein 1 MH - *Nerve Degeneration/prevention & control MH - *Neuroprotective Agents MH - Rats, Wistar MH - *Signal Transduction/drug effects/physiology MH - *Substantia Nigra/cytology/drug effects/physiology MH - Sympatholytics MH - *NF-E2-Related Factor 2/biosynthesis OTO - NOTNLM OT - BDNF OT - Nrf2/ARE signaling pathway OT - Oxidative stress OT - Parkinson's disease OT - Puerarin OT - Substantia nigra EDAT- 2013/06/12 06:00 MHDA- 2014/02/05 06:00 CRDT- 2013/06/11 06:00 PHST- 2013/01/17 00:00 [received] PHST- 2013/04/13 00:00 [revised] PHST- 2013/05/28 00:00 [accepted] PHST- 2013/06/11 06:00 [entrez] PHST- 2013/06/12 06:00 [pubmed] PHST- 2014/02/05 06:00 [medline] AID - S0006-8993(13)00809-3 [pii] AID - 10.1016/j.brainres.2013.05.046 [doi] PST - ppublish SO - Brain Res. 2013 Jul 26;1523:1-9. doi: 10.1016/j.brainres.2013.05.046. Epub 2013 Jun 5.